Product NDC: | 17156-235 |
Proprietary Name: | AdreView |
Non Proprietary Name: | Iobenguane I-123 |
Active Ingredient(s): | 2 mCi/mL & nbsp; Iobenguane I-123 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17156-235 |
Labeler Name: | Medi-Physics Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022290 |
Marketing Category: | NDA |
Start Marketing Date: | 20080919 |
Package NDC: | 17156-235-01 |
Package Description: | 1 VIAL, GLASS in 1 CONTAINER (17156-235-01) > 5 mL in 1 VIAL, GLASS |
NDC Code | 17156-235-01 |
Proprietary Name | AdreView |
Package Description | 1 VIAL, GLASS in 1 CONTAINER (17156-235-01) > 5 mL in 1 VIAL, GLASS |
Product NDC | 17156-235 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Iobenguane I-123 |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20080919 |
Marketing Category Name | NDA |
Labeler Name | Medi-Physics Inc. |
Substance Name | IOBENGUANE I-123 |
Strength Number | 2 |
Strength Unit | mCi/mL |
Pharmaceutical Classes |